Stein, B L
Swords, R
Hochhaus, A
Giles, F
Article History
Received: 17 February 2014
Revised: 25 April 2014
Accepted: 7 May 2014
First Online: 3 June 2014
Competing interests
: BLS was previously a member of Speakers Bureau, Incyte Corporation and has participated in Advisory Boards for Incyte Corporation and Sanofi Oncology. RS has declared no conflict of interest. AH has received honoraria and research funding from Novartis, Bristol-Myers Squibb and Pfizer; and FG has received honoraria and research funding from Novartis.